Cartesian Therapeutics Inc. PS Ratio 2016–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Current and historical P/S ratio for Cartesian Therapeutics Inc. (RNAC): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 412.90.

From: 06/30/2016To: 03/31/2026

Stock Price

TTM Revenue

PS Ratio

Cartesian Therapeutics Inc. PS Ratio — FAQ

Cartesian Therapeutics Inc. (RNAC) ps ratio over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RNAC's ps ratio history?

The chart and table above show Cartesian Therapeutics Inc.'s ps ratio by year and by quarter, including the growth rate.